• NIH awards $577,000 to ImmuRx for treatment of tuberculosis

    ImmuRx, co-founded by Ross Kedl, PhD, assistant professor in the department of Immunology at the University of Colorado Denver School of Medicine, has been awarded a $577,000 Small Business Innovation Research (SBIR) award from the National Institutes of Health (NIH) to study the potential of the ImmuRx platform to treat tuberculosis (TB).… Full Story

    November 3, 2009
    Caitlin Jenney
  • Tanning associated with moles in very light-skinned children

    Increases the risk of melanoma/skin cancer later in life A new study led by researchers at the Colorado School of Public Health at the University of Colorado Denver has found very light-skinned children who tan appear to develop more moles on the skin than children who do not tan.… Full Story

    October 8, 2009
    Guest Contributor